Pulmonx Corporation (FRA:4NI)

Pulmonx Statistics

Total Valuation

Pulmonx has a market cap or net worth of EUR 72.34 million. The enterprise value is 55.16 million.

Market Cap	72.34M
Enterprise Value	55.16M

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	41.25M
Shares Outstanding	n/a
Shares Change (YoY)	+3.66%
Shares Change (QoQ)	+1.25%
Owned by Insiders (%)	4.38%
Owned by Institutions (%)	72.67%
Float	39.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.93
PB Ratio	1.41
P/TBV Ratio	1.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.14
EV / Sales	0.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.99

Financial Position

The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.94.

Current Ratio	4.86
Quick Ratio	3.97
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	-1.74
Interest Coverage	-17.72

Financial Efficiency

Return on equity (ROE) is -73.73% and return on invested capital (ROIC) is -26.84%.

Return on Equity (ROE)	-73.73%
Return on Assets (ROA)	-23.38%
Return on Invested Capital (ROIC)	-26.84%
Return on Capital Employed (ROCE)	-49.55%
Revenue Per Employee	268,472
Profits Per Employee	-166,222
Employee Count	291
Asset Turnover	0.60
Inventory Turnover	1.47

Taxes

In the past 12 months, Pulmonx has paid 407,399 in taxes.

Income Tax	407,399
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	14

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.13

Income Statement

In the last 12 months, Pulmonx had revenue of EUR 78.13 million and -48.37 million in losses. Loss per share was -1.20.

Revenue	78.13M
Gross Profit	57.26M
Operating Income	-48.73M
Pretax Income	-47.96M
Net Income	-48.37M
EBITDA	-47.78M
EBIT	-48.73M
Loss Per Share	-1.20

Balance Sheet

The company has 65.24 million in cash and 48.21 million in debt, with a net cash position of 17.03 million.

Cash & Cash Equivalents	65.24M
Total Debt	48.21M
Net Cash	17.03M
Net Cash Per Share	n/a
Equity (Book Value)	51.17M
Book Value Per Share	1.24
Working Capital	75.31M

Cash Flow

In the last 12 months, operating cash flow was -27.29 million and capital expenditures -468,765, giving a free cash flow of -27.76 million.

Operating Cash Flow	-27.29M
Capital Expenditures	-468,765
Free Cash Flow	-27.76M
FCF Per Share	n/a

Margins

Gross margin is 73.30%, with operating and profit margins of -62.38% and -61.91%.

Gross Margin	73.30%
Operating Margin	-62.38%
Pretax Margin	-61.39%
Profit Margin	-61.91%
EBITDA Margin	-61.16%
EBIT Margin	-62.38%
FCF Margin	n/a

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.66%
Shareholder Yield	-3.66%
Earnings Yield	-66.87%
FCF Yield	-38.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pulmonx has an Altman Z-Score of -3.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.62
Piotroski F-Score	3